PT-141

Melanocortin receptor agonist acting on MC3R and MC4R in the CNS. Approved as Bremelanotide for treating hypoactive sexual desire disorder.

2 anonymous reports
StackingPeptides for Sex DrivePeptides for Weight LossPeptides for RecoveryPeptides for WomenBest Peptide Stacks

Also known as:

pt141pt 141bremelanotide

browse topics:

Peptides for Women

community guides:

Reconstituting PeptidesInjecting Peptides

I'm a woman and nobody talks about this honestly so I will: PT-141 works on us too. works on my fiancé as well. that's the one peptide in my whole stack that delivered exactly what it promised with zero ambiguity. tirz and reta both work (reta's so strong even a low dose kills my appetite completely), MOTS gave me real sustained energy, and BPC/TB/KLOW did absolutely nothing for me. but the one I'd never quit is the one nobody puts on a tier list.

#117
StackingPeptides for Sex DrivePeptides for Weight LossPeptides for RecoveryPeptides for WomenBest Peptide Stacks

I'm 38. married 9 years. I haven't been able to finish with my wife in over a year. Tried cialis daily works for the erection, nothing for the rest. Added PT-141 nasal spray 45 min before. first time in 14 months I felt like a person in my own body during sex. PT-141 + tadalafil 5mg daily. that's the stack. I will probably never be able to stop.

#067
StackingPeptides for Sex DrivePeptides for WomenBest Peptide Stacks

Community Q&A

What does PT-141 do?
Community accounts consistently describe PT-141 as producing centrally-mediated sexual arousal — increased desire and sensitivity rather than purely a mechanical response. Female accounts describe heightened desire and sensation; male accounts describe stronger arousal and, in some cases, improved erections. The mechanism is described in accounts as distinct from PDE5 inhibitors (Viagra/Cialis) — acting on the brain rather than blood vessels. This distinction appears frequently in accounts from users who found PDE5 inhibitors insufficient.
How long does PT-141 last?
Community accounts describe the onset at 30–90 minutes after subcutaneous injection, with peak effects at 1–3 hours and duration of 6–12 hours in most reports. Some accounts describe residual effects into the following day. Nausea appears in a portion of accounts, typically within the first hour — described as manageable and dose-dependent. Accounts that dose too frequently report diminishing returns, with most conventions suggesting use no more than twice per week.
Is PT-141 safe for women?
Female community accounts describe PT-141 as well-tolerated at moderate doses. The most commonly reported female-specific experiences: significantly increased desire, enhanced sensitivity, and in some accounts reduced anxiety around intimacy. Nausea appears in female accounts at a similar rate to male accounts — usually in the first use and improving with subsequent doses. Accounts from women with HSDD (hypoactive sexual desire disorder) appear frequently, framing it as more effective than other treatments they had tried.